Showing results (1-10 of 95) with videos related to
Sort By:
Pageof 10
Disease Markers|December 19, 2013
Circulating autoantibodies to LGALS3BP: a novel biomarker for cancerAntonino Grassadonia, Nicola Tinari, Clara Natoli, et al.Journal of Cancer Research and Clinical Oncology|November 19, 2011
Meta-analysis of phase III trials of docetaxel alone or in combination with chemotherapy in metastatic breast cancerMaurizio Belfiglio, Caterina Fanizza, Nicola Tinari, et al.Cancers|November 9, 2013
Role of Hydroxamate-Based Histone Deacetylase Inhibitors (Hb-HDACIs) in the Treatment of Solid MalignanciesAntonino Grassadonia, Pasquale Cioffi, Felice Simiele, et al.Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|September 20, 2018
Adherence to hormonal deprivation therapy in prostate cancer in clinical practice: a retrospective, single-center studyAntonio Aliberti, Maida Bada, Sebastiano Rapisarda, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 11, 2012
Effectiveness and response predictive factors of erlotinib in a non-small cell lung cancer unselected European population previously treated: a retrospective, observational, multicentric studyPasquale Cioffi, Valerio Marotta, Caterina Fanizza, et al.Cancer Letters|July 1, 2008
Sunitinib malate (SU-11248) alone or in combination with low-dose docetaxel inhibits the growth of DU-145 prostate cancer xenograftsAlbana Cumashi, Nicola Tinari, Cosmo Rossi, et al.Medical Hypotheses|November 27, 2012
Tumor-derived microvesicles: the metastasomesReza Ghasemi, Antonino Grassadonia, Nicola Tinari, et al.Current Cancer Drug Targets|February 8, 2012
An epigenetic approach to pancreatic cancer treatment: the prospective role of histone deacetylase inhibitorsNicola Tinari, Michele De Tursi, Antonino Grassadonia, et al.Cancer Biology & Therapy|November 11, 2015
Is the skin a sanctuary for breast cancer cells during treatment with anti-HER2 antibodies?Vincenzo Graziano, Maria Teresa Scognamiglio, Marinella Zilli, et al.International Medical Case Reports Journal|March 28, 2020
Alectinib Induced Regression of Renal and Hepatic Cysts Caused by CrizotinibPietro Di Marino, Gianluca Mannetta, Consiglia Carella, et al.Pageof 10